Jupiter Neurosciences, Inc.

JUNS Nasdaq SEC CIK 1679628
Follow Jupiter Neurosciences Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $13.9K
Net income −$7.2M −215.7% vs same quarter last year
EPS, diluted −$7.42
Operating cash flow −$2.7M −135.6% vs same quarter last year
Revenue by quarter
$0
$18.7K
$24.2K
$13.9K
Q1 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income4 fiscal years
−$10M−$7.5M−$5M−$2.5M$0FY22FY23FY24FY25
Show the numbers
YearNet income
FY25−$8.6M
FY24−$2.4M
FY23−$4.8M
FY22-